Philip Burnham
Chief Scientific Officer Kanvas Biosciences
Phil serves as the Chief Scientific Officer at Kanvas Biosciences. Phil honed his skills in FISH-based measurement techniques as a postdoctoral fellow at the University of Pennsylvania. Motivated by a pursuit to advance biotechnology and enhance human health, Phil has pioneered innovative diagnostic techniques for infectious diseases, employing DNA sequencing and single-cell ‘omics methodologies. He has also developed image-based screening techniques to study tissue regeneration processes in both injury and disease in the GI tract. After obtaining a Bachelor of Science from Villanova, Phil received his Ph.D from Cornell University.
Seminars
Measuring complex, multi-strain microbiome products remains inconsistent, with biased culture assays, unclear regulatory expectations, and no validated industry standards. This workshop shows how to adopt novel assay technologies and build product-specific analytical strategies that demonstrate identity, potency, and viability, enabling confident regulatory interactions.
Workshop highlights:
- Assessing emerging technologies that quantify complex microbial consortia while capturing strain-level identity and live viability without biased culture workflows.
- Defining product-specific analytical strategies aligned with evolving FDA expectations to validate potency identity and release assays across development stages.
- Comparing approaches to measure multi-strain abundance and function including sequencing viability assays and synthetic biology readouts to strengthen mechanism claims.
- Walking through end-to-end processes for selecting labs piloting methods and validating assays to generate reproducible data satisfying regulators.
